News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
869,165 Results
Type
Article (87891)
Company Profile (825)
Press Release (780434)
Multimedia
Podcasts (191)
Webinars (28)
Section
Business (233232)
Career Advice (4145)
Deals (39866)
Drug Delivery (145)
Drug Development (91397)
Employer Resources (203)
FDA (18377)
Job Trends (17420)
News (397841)
Policy (39959)
Tag
Academia (3006)
Academic (2)
Accelerated approval (33)
Adcomms (36)
Allergies (142)
Alliances (56981)
ALS (180)
Alzheimer's disease (1783)
Antibody-drug conjugate (ADC) (335)
Approvals (18544)
Artificial intelligence (612)
Autoimmune disease (154)
Automation (34)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (198)
Biotechnology (489)
Bladder cancer (159)
Brain cancer (64)
Breast cancer (645)
Cancer (4914)
Cardiovascular disease (433)
Career advice (3567)
Career pathing (40)
CAR-T (300)
CDC (59)
Celiac Disease (1)
Cell therapy (814)
Cervical cancer (37)
Clinical research (76883)
Collaboration (1745)
Company closure (5)
Compensation (1121)
Complete response letters (70)
COVID-19 (2987)
CRISPR (96)
C-suite (825)
Cystic fibrosis (154)
Data (6140)
Decentralized trials (2)
Denatured (70)
Depression (145)
Diabetes (524)
Diagnostics (7207)
Digital health (44)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (294)
Drug pricing (219)
Drug shortages (36)
Duchenne muscular dystrophy (232)
Earnings (100031)
Editorial (61)
Employer branding (25)
Employer resources (173)
Events (134953)
Executive appointments (1023)
FDA (21447)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1529)
Gene editing (210)
Generative AI (62)
Gene therapy (659)
GLP-1 (1109)
Government (5432)
Grass and pollen (8)
Guidances (382)
Healthcare (20941)
HIV (60)
Huntington's disease (48)
IgA nephropathy (86)
Immunology and inflammation (287)
Immuno-oncology (52)
Indications (84)
Infectious disease (3271)
Inflammatory bowel disease (202)
Inflation Reduction Act (17)
Influenza (118)
Intellectual property (239)
Interviews (816)
IPO (17952)
IRA (60)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (89)
Layoffs (656)
Leadership (39)
Legal (10156)
Liver cancer (97)
Longevity (14)
Lung cancer (670)
Lymphoma (368)
Machine learning (42)
Management (66)
Manufacturing (816)
MASH (171)
Medical device (14999)
Medtech (15043)
Mergers & acquisitions (22949)
Metabolic disorders (1363)
Multiple sclerosis (157)
NASH (23)
Neurodegenerative disease (341)
Neuropsychiatric disorders (93)
Neuroscience (3065)
NextGen: Class of 2026 (7707)
Non-profit (5109)
Now hiring (63)
Obesity (656)
Opinion (331)
Ovarian cancer (162)
Pain (198)
Pancreatic cancer (225)
Parkinson's disease (288)
Partnered (38)
Patents (490)
Patient recruitment (454)
Peanut (60)
People (66814)
Pharmaceutical (145)
Pharmacy benefit managers (31)
Phase I (23761)
Phase II (33357)
Phase III (25148)
Pipeline (4664)
Policy (328)
Postmarket research (3554)
Preclinical (10682)
Press Release (72)
Prostate cancer (238)
Psychedelics (53)
Radiopharmaceuticals (298)
Rare diseases (864)
Real estate (7437)
Recruiting (80)
Regulatory (28855)
Reports (65)
Research institute (2721)
Resumes & cover letters (651)
Rett syndrome (27)
RNA editing (19)
RSV (83)
Schizophrenia (157)
Series A (254)
Series B (193)
Service/supplier (30)
Sickle cell disease (103)
Special edition (27)
Spinal muscular atrophy (175)
Sponsored (47)
Startups (4333)
State (2)
Stomach cancer (20)
Supply chain (111)
Tariffs (98)
The Weekly (119)
Vaccines (1128)
Venture capital (92)
Weight loss (453)
Women's health (85)
Worklife (21)
Date
Today (66)
Last 7 days (789)
Last 30 days (2201)
Last 365 days (33218)
2026 (1478)
2025 (33226)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (87)
Alaska (7)
Arizona (339)
Arkansas (14)
Asia (51482)
Australia (9033)
California (11314)
Canada (3255)
China (1129)
Colorado (477)
Connecticut (492)
Delaware (340)
Europe (118286)
Florida (1655)
Georgia (363)
Hawaii (3)
Idaho (68)
Illinois (941)
India (65)
Indiana (533)
Iowa (23)
Japan (412)
Kansas (132)
Kentucky (42)
Louisiana (29)
Maine (82)
Maryland (1439)
Massachusetts (8374)
Michigan (349)
Minnesota (649)
Mississippi (6)
Missouri (137)
Montana (35)
Nebraska (28)
Nevada (122)
New Hampshire (85)
New Jersey (3061)
New Mexico (33)
New York (3001)
North Carolina (1584)
North Dakota (10)
Northern California (5394)
Ohio (347)
Oklahoma (22)
Oregon (54)
Pennsylvania (2266)
Puerto Rico (20)
Rhode Island (49)
South America (1657)
South Carolina (62)
South Dakota (1)
Southern California (4355)
Tennessee (173)
Texas (1786)
United States (40943)
Utah (339)
Vermont (1)
Virginia (283)
Washington D.C. (85)
Washington State (949)
West Virginia (4)
Wisconsin (122)
Wyoming (2)
There are 869,165 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Jazz Sells Priority Review Voucher for $200M as Program’s Renewal Languishes in Senate
Half of the net proceeds will go to Jazz; it remains unclear who will get the remaining sum. Jazz did not reveal the buyer of the voucher.
January 15, 2026
·
2 min read
·
Tristan Manalac
Rare diseases
JPM Day 3: Rare Disease in the Spotlight
2026 is shaping up to be a pivotal year for rare disease drugmakers, with key approvals, filings and readouts lined up for this year.
January 15, 2026
·
5 min read
·
Tristan Manalac
Editorial
JPM26: Verizon Outage Unites Directionless Conference Goers
It doesn’t matter how many times you have traversed Union Square; no one knows which way is north, or where The Westin is in relation to the Ritz Carlton. A Verizon outage brought that into focus on Wednesday.
January 15, 2026
·
1 min read
·
Annalee Armstrong
Press Releases
JPM Highlights | WuXi Biologics CEO Dr. Chris Chen: Scaled CRDMO Platform Delivering Sustainable High Growth
January 15, 2026
·
9 min read
Press Releases
Hyundai Bioscience Confirms Entry into U.S. FDA Phase 2 Trials for Broad-Spectrum Antiviral ‘XAFTY’ Following 2026 Biotech Showcase Consensus
January 15, 2026
·
3 min read
Press Releases
Flashpoint Therapeutics Appoints Venkat R. Krishnamurthy, Ph.D. as Chief Scientific Officer
January 15, 2026
·
3 min read
Press Releases
Adolore BioTherapeutics Announces FDA Orphan Drug Designation for its Kv7-activating rdHSV-CA8* Therapy in the Treatment of Erythromelalgia
January 15, 2026
·
7 min read
Press Releases
Transneural Therapeutics Presents Preclinical Data on Lead Candidate TN-001 at 64th Annual Meeting of ACNP (2026)
January 15, 2026
·
3 min read
Press Releases
Centessa Pharmaceuticals Announces Poster Presentation of New Preclinical Data Supporting Expansion of Orexin Receptor 2 (OX2R) Agonist Pipeline into Neuropsychiatric Indications at the 64th ACNP Annual Meeting
January 15, 2026
·
7 min read
Press Releases
AJOVY® (fremanezumab-vfrm) Significantly Reduced Monthly Migraine and Headache Days in Children and Adolescents with Episodic Migraine Compared to Placebo in the SPACE Trial; Results Published in New England Journal of Medicine
January 15, 2026
·
9 min read
1 of 86,917
Next
